关于与乐普罗雷林相关的营销后副作用的新见解:利用FAERS数据库进行全面分析
Huawei Han1, Xinping Bu2, Xinzhe Wang3
1Department of Orthopedics, The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Heliyon
|August 19, 2024
概括
这项研究发现了与前列腺癌和子宫内膜异位症治疗药物罗林相关的新药不良反应. 持续监测对于患者安全和有效的治疗管理至关重要.
科学领域:
- 药物监督 药物监督 药物监督
- 药物安全研究 药物安全研究
- 临床药理学 临床药理学
背景情况:
- 罗林是一种广泛使用的GnRH激动剂,用于治疗激素敏感性疾病,如前列腺癌,子宫内膜异位症,子宫纤维瘤和早发性.
- 确保患者的安全需要持续监测与罗雷林治疗相关的不良药物反应 (ADR).
研究的目的:
- 细致地跟踪和识别与leuprorelin相关的不良反应.
- 为了提高患者的安全性,并提供关于罗林适当使用的知情指导.
主要方法:
- 来自FDA不良事件报告系统 (FAERS) 数据库的大量不良事件报告 (AER) 数据集的分析.
- 利用数据挖掘和不成比例分析,使用ROR,PRR,BCPNN和EBGM等算法来检测安全信号.
主要成果:
- 在24个系统器官类 (SOC) 中确定了102个积极反应项 (PT),来自60,709份乐普罗雷林报告.
- 发现了以前未被识别的不良反应,包括人工更年期,卵巢粘附,卵泡囊炎和产品/药物错误.
- 突出显示了潜在的不良影响,如无菌,注射部位颗粒瘤和先天性球脊髓肌肉缩.
结论:
- 成功识别了普罗雷林给药后出现的新奇和意想不到的不良药物反应信号.
- 强调持续药物监测和监测对于及时识别和管理不良事件至关重要.
- 这些发现有助于对乐普罗雷林的ADR概况有价值的见解,加强了警患者安全措施的必要性.
相关概念视频
01:21Factors Affecting Drug Response: Overview
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).